Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats
Authors:
- Yong-Xin LuYLYong-Xin Lu
- Yu-Hua LiaoYLYu-Hua Liao
- Xiao-Lin WangXWXiao-Lin Wang
- Yong-Jin WangYWYong-Jin Wang
- Chao ChangCCChao Chang
- Yu-Qin WangYWYu-Qin Wang
- Qi-Yun LiuQLQi-Yun Liu
- Yan-Zhang GaoYGYan-Zhang Gao
- Shao-Hua MiSMShao-Hua Mi
Open Access
- 1 February 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 121 (4) , 347-354
Abstract
Cell transplantation for myocardial repair is limited by early cell death. Gene therapy with human growth hormone (hGH) has been shown to promote angiogensis and attenuate apoptosis in the experimental animal. This study was conducted to explore the effects of myoblast-based hGH gene therapy on heart function restoration and angiogenesis after myocardial infarction, and to compare the differences between myoblast-based hGH gene therapy and myoblast therapy. Myoblasts were isolated from several SD rats, cultured, purified, and transfected with plasmid pLghGHSN and pLgGFPSN. Radioimmunoassay (RIA) was used to detect the expression of hGH in these myoblasts. SD rats underwent the ligation of the left anterior descending coronary artery so as to establish a heart ischemia model. Thirty surviving rats that underwent ligation were randomly divided into 3 equal groups 2 weeks after left coronary artery occlusion: pLghGHSN group received myoblast infected with hGH gene transplantation; pLgGFPSN group received myoblast infected with GFP gene transplantation; control group: received cultured medium only. Four weeks after the injection the surviving rat underwent evaluation of cardiac function by echocardiography. The rats were killed and ventricular samples were undergone immunohistochemistry with hematoxylin-eosin and factor VIII. Cryosection was analyzed by fluorescence microscopy to examine the expression of green fluorescent protein. Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to examine the mRNA expression of vascular endothelial growth factor (VEGF), bax and Bcl-2. hGH expression in myocardium was examined by Western blot. Myoblast can be successfully isolated, cultured and transfected. The expression of hGH in transfected myoblast was demonstrated with RIA. Four weeks after therapy, the cardiac function was improved significantly in pLghGHSN group and pLgGFPSN group. Fractional shortening (FS) and ejection fraction (EF) in pLghGHSN group were elevated significantly compared with pLgGFPSN group and control group after therapy (FS: 36.9±5.3 vs 29.5±3.5, 21.8±2.9; EF: 56.9±4.3 vs 47.1±3.6, 38.4±4.8, P<0.05). Left ventricular end-diastolic dimension (LVEDD) and heart infracted size in pLghGHSN group were decreased significantly compared with pLgGFPSN group and control group after therapy (LVEDD: 5.9±0.3 vs 6.8±0.2, 8.6±0.3; heart infracted size: (34.5±4.2)% vs (40.0±3.9)%, (46.1±3.8)%, P<0.05); Green fluorescence was detected in cryosection of pLgGFPSN group. The capillary density of the pLgGFPSN group was significantly greater than those of the pLghGHSN group and control group (P<0.05). The mRNA expression of VEGF and Bcl-2/bax in pLghGHSN group was higher than in pLgGFPSN group or control group (P<0.05). The expression of hGH gene in myocardium tissue can be detected by Western blot assay in pLghGHSN group. Transplantation of heart cells transfected with hGH induced greater angiogenesis and effect of antiapoptosis than transplantation of cells transfected with GFP. Combined GH gene transfer and cell transplantation provided an effective strategy for improving postinfarction ventricular function.Keywords
This publication has 32 references indexed in Scilit:
- Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular functionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic CardiomyopathyCirculation, 2005
- Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reactionThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathyJournal of Molecular and Cellular Cardiology, 2004
- Retrovirus vector production and transduction: modulation by the cell cycleJournal of General Virology, 2003
- Transplanted Skeletal Myoblasts Can Fully Replace the Infarcted Myocardium When They Survive in the Host in Large NumbersCirculation, 2003
- Survival and Development of Neonatal Rat Cardiomyocytes Transplanted into Adult MyocardiumJournal of Molecular and Cellular Cardiology, 2002
- Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death StrategiesJournal of Molecular and Cellular Cardiology, 2001
- Protective responses in the ischemic myocardiumJournal of Clinical Investigation, 2000